Patent ID: 9632074
Date: 2017-04-25
CPC Classifications: A61K,A61P,B65D,G01N

Claim:
1. A method for: overcoming or diminishing a Growth Factor Inhibitor (GFI) resistance in a cell, or sensitizing, increasing sensitivity to or re-sensitizing a tumor that is resistant to a cancer or anti-tumor Growth Factor Inhibitor (GFI) drug, wherein the Growth Factor Inhibitor is an erlotinib, a linsitinib, a lapatinib or a lenalidomide, comprising administering to the cell or an individual in need thereof at least one compound, composition or formulation comprising an inhibitor of Galectin-3; thereby overcoming or diminishing the Growth Factor Inhibitor (GFI) resistance in the cell, or sensitizing, increasing sensitivity or re-sensitizing the tumor that is resistant to the cancer or anti-tumor Growth Factor Inhibitor (GFI) drug.